Ajax-Loading

Astellas Pharma Inc. - Net Interest Income

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Interest-Income" stands at -0.062 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the highest value since 09/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.055 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 0.055 Billion Japanese Yens.
The 3 year change is -2.61 Billion Japanese Yens.
The 5 year change is -3.18 Billion Japanese Yens.

The Serie's long term average value is 2.03 Billion Japanese Yens. It's latest available value, on 12/31/2024, is -2.10 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2024, to it's latest available value, on 12/31/2024, is +1.65 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2021, to it's latest available value, on 12/31/2024, is -9.65 Billion.

Net Interest Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Interest Income905,699,262,464.00
LogoJohnson & Johnson - Net Interest Income486,508,953,600.00
LogoAbbVie Inc - Net Interest Income399,570,305,024.00
LogoRoche Holding AG - Net Interest Income317,433,206,677.55
LogoAstraZeneca PLC - Net Interest Income280,205,508,085.11